Life Sciences

Retention of Intellectual Property and Speed to Market

Automation is a key component in verifying quality and speed in the ever-expanding Life Sciences industry. Flexible packaging, strict batching standards, validation, operational visualization, secured and detailed data collection and advanced process control are common in FDA regulated industries, and a major financial investment for drug manufacturing companies.

A common problem within Life Sciences manufacturing is the need for standardization, and the Client-wide reuse of validated code, objects, documentation and the retention of intellectual property. Not only does the limited reuse of project content lead to a higher engineering investment, the problem is compounded by extensive re-testing and documentation requirements associated with validation procedures associated with a company’s GAMP standards.

The Most Expensive Engineering is Re-Engineering

GGS offers a unique and proven object oriented methodology to help Life Science manufactures deal with the retention of intellectual property and engineering re-use. GGS can provide a strategic roadmap and engineering services for object development, and provide PMP Project Managers to verify the proper deployment of a global code and documentation database.

Knowledge From Experience

GGS has experience in the development and delivery of systems that must serve regulatory compliance first but without sacrificing production efficiency. From the manufacturer of eye solutions to production of filtration media for use in dialysis processes we have seen a variety of applications in the Life Sciences industry including:

  • Batch
  • Sterile Filling
  • Vision Inspection
  • Quality Management Systems
  • Bagging
  • Discrete Automation
  • Product Assembly
  • System Validation and 21 CFR 11 compliance